Nomura Holdings Inc Moderna, Inc. Put Options Transaction History

Nomura Holdings Inc

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $26.3 Million - $43.4 Million	260,300 New	260,300 $30.9 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $1.65 Million - $2.47 Million	-23,700 Reduced 91.86%	2,100 $208,000
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $115,692 - $151,932	-1,200 Reduced 4.44%	25,800 $2.66 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $1.42 Million - $1.93 Million	12,000 Added 80.0%	27,000 $3.28 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $2.03 Million - $2.96 Million	15,000 New	15,000 $2.3 Million
Q3 2022 Nov 15, 2022	SELL	$118.07 - $194.18 $23,614 - $38,836	-200 Reduced 14.29%	1,200 $143,000
Q1 2022 May 18, 2022	BUY	$126.46 - $235.05 $151,752 - $282,060	1,200 Added 600.0%	1,400 $248,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $77.9 Million - $127 Million	-344,800 Reduced 99.94%	200 $50,000
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $18.7 Million - $32.7 Million	345,000 New	345,000 $24.4 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.